SK pharmteco is the single market-facing team comprised of SK biotek, AMPAC Fine Chemicals & Yposkesi. Creating substantial market synergies in the API & Cell & Gene Therapy CDMO space by combining highly complementary assets & expertise this union enables us to provide the highest-quality services to our customers. With world-class state-of-the-art facilities & technology, increased capabilities: energetic chemistry, continuous flow process, chromatography, controlled substances, particle engineering, viral vectors, ADC Payloads & Linkers, HPAPI - with world-class potent handling capability (down to low nanogram per cubic meter levels). We have multiple cGMP manufacturing and development sites, with >1000 m³ of capacity among 9 sites US, Korea, France & Ireland. Our scientists & engineers are leaders in continuous manufacturing methodologies, having successfully developed processes from low kilograms through to 10s of tonnes. We are a world leader in SMB & offer this powerful technology from lab through pilot to large commercial scale. We have a proven track record in successfully developing processes involving highly energetic chemistry & now offer supply capability for Controlled Substances from our DEA-approved facilities in Virginia & California. In addition to providing analytical development and validation for all of the products that we manufacture in our global network, we also provide this same service for other customers as a stand-alone business at our Analytical Services facilities in Dublin & California. As leaders in operational excellence & continuous improvement & boast exceptional technical capabilities. The global presence of our highly skilled and experienced team offers total support from development through to commercial production including seamless project transfer and management plus flexibility in R&D and manufacturing. All our plants have been approved by global regulatory agencies including the FDA, EMEA, PDMA & Korean MFDS.